Skip to content
ProPublica Donate
ProPublica Donate

Access To Advanced Health Institute

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Medical Research / Specifically Named Diseases Research (NTEE)

Donations to this organization are tax deductible.

Details

According to its Dec. 2022 tax filing, this nonprofit:

Reported conflict of interest transactions
Organizations must report loans, grants or business transactions with interested parties, which may include key employees and officers, their family members and any businesses in which they hold a controlling interest. These transactions must be reported on Schedule L.

Summary charts: organization finances over time

Revenue
$51.2M (2022)

Expenses
$21.4M (2022)

Total Assets
$42.8M (2022)

Total Liabilities
$16.9M (2022)

Source: Form 990 tax filings from 2011 to 2022

Tax Filings and Audits by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Audits are required to be submitted by nonprofit organizations that spend $750,000 or more in federal grant money in a fiscal year. "Single audits" look at the entire organization's finances and compliance, while other audits are program specific. Nonprofit Explorer has PDFs of audits for some nonprofits for fiscal year 2015 and later. Audit data is from the Federal Audit Clearinghouse.

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$51,186,254
Expenses
$21,362,457
Net Income
$29,823,797
Net Assets
$25,912,765
Notable Sources of Revenue Percent of Total Revenue
Contributions $33,420,108
65.3%
Program Services $17,386,494
34.0%
Investment Income $43,387
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $196,036
0.4%
Net Fundraising $0
Sales of Assets $18,600
0.0%
Net Inventory Sales $0
Other Revenue $121,629
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,400,903
15.9%
Professional Fundraising Fees $0
Other Salaries and Wages $4,863,246
22.8%
Assets/Debt
Total Assets $42,840,477
Total Liabilities $16,927,712
Net Assets $25,912,765
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Corey Casper (Ceo, President) $626,233 $0 $33,881
Jerry Kuo (Coo & Cfo, Treasurer) $336,867 $0 $41,555
Candice Decaire (Chief Strategy Officer, Secretary) $333,957 $0 $30,338
Anna Marie Beckmann (Evp, Product Development) $273,578 $0 $35,556
Christopher Fox (Senior Vp Of Formulations) $252,186 $0 $46,526
Linda Hawkins (Dir. Quality Assurance) $196,618 $0 $33,642
Robrick Smith (Dir. Information Technology) $191,231 $0 $36,622
Alan Lew (Senior Clinical Trial Manager) $164,664 $0 $21,066
Darren Klemkow (Dir. Facilities & Procurement) $161,337 $0 $30,284
Lisa Mcneill (Dir. Manufacturing) $160,719 $0 $19,786
Harnik Gulati (Dir. Project Management) $152,224 $0 $17,955
Jeffrey Guderian (Dir. Laboratory Management) $151,752 $0 $26,407
Emily Voigt (Principal Scientist) $147,121 $0 $37,150
Zachary Sagawa (Dir. Clinical Research & Reg. Affairs) $141,190 $0 $31,325
John Argerious (Associate Director, Business Admin) $129,738 $0 $26,833
Damon Pang (Corporate Counsel) $129,630 $0 $26,800
Lisa Bouchard (Dir. Quality Control) $128,590 $0 $22,109
Shelly Crocker (Receiver Thru 02/22) $0 $0 $0
Patrick Soon Shiong (Board Member) $0 $0 $0
David Kerr (Board Member) $0 $0 $0
Edward Mocarski (Board Member) $0 $0 $0
Edward Hsu (Board Member) $0 $0 $0
Glenda Gray (Board Member) $0 $0 $0
Raoul Concepcion (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$25,258,154
Expenses
$22,297,762
Net Income
$2,960,392
Net Assets
-$3,750,739
Notable Sources of Revenue Percent of Total Revenue
Contributions $6,701,932
26.5%
Program Services $12,880,960
51.0%
Investment Income $1,746
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $85,040
0.3%
Net Fundraising $0
Sales of Assets $1,000
0.0%
Net Inventory Sales $0
Other Revenue $5,587,476
22.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,013,261
9.0%
Professional Fundraising Fees $0
Other Salaries and Wages $4,291,537
19.2%
Assets/Debt
Total Assets $16,228,599
Total Liabilities $19,979,338
Net Assets -$3,750,739
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Corey Casper (Ceo) $438,281 $0 $18,667
Candice Decaire (Chief Strat. Officer & Gen. Couns.) $265,625 $0 $22,512
Neil O'connor (Cfo & Coo Thru 12/21) $255,208 $0 $30,003
Anna Marie Beckmann (Evp, Product Development) $254,688 $0 $30,214
Christopher Fox (Senior Vp, Formulations) $229,746 $0 $32,109
Linda Hawkins (Dir., Quality Assurance & Comp.) $183,056 $0 $27,270
Robrick Smith (Dir., Information Technology) $179,933 $0 $28,132
Erik Laursen (Dir., Gmp Operations) $146,700 $0 $16,713
Lisa Mcneill (Dir., Manufacturing) $145,207 $0 $17,244
Harnik Gulati (Dir., Strategy & Prgrm Management) $142,625 $0 $16,739
Darren Klemkow (Dir., Facilities & Procurement) $141,750 $0 $27,533
Jeffrey Guderian (Dir., Laboratory Management) $139,245 $0 $19,148
Jerry Kuo (Coo & Cfo) $17,817 $0 $0
Shelly Crocker (Receiver) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$13,342,560
Expenses
$19,814,751
Net Income
-$6,472,191
Net Assets
-$6,410,088
Notable Sources of Revenue Percent of Total Revenue
Contributions $3,584,439
26.9%
Program Services $10,969,518
82.2%
Investment Income $532
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$1,720,182
Net Inventory Sales $0
Other Revenue $508,253
3.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,397,163
7.1%
Professional Fundraising Fees $0
Other Salaries and Wages $4,084,274
20.6%
Assets/Debt
Total Assets $13,563,097
Total Liabilities $19,973,185
Net Assets -$6,410,088
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Corey Casper (Ceo) $397,292 $0 $16,073
Anna Marie Beckmann (Evp, Product Development) $207,514 $0 $26,192
Christopher Fox (Vp, Formulations) $171,814 $0 $28,190
Neil O'connor (President & Coo) $162,179 $0 $21,130
Linda Hawkins (Dir. Quality Assurance & Compliance) $160,321 $0 $24,254
Cynthia Shumate (General Counsel & Sec. Thru 07/20) $157,812 $0 $14,877
Robrick Smith (Director, Information Technology) $156,276 $0 $25,928
Erik Laursen (Dir. Gmp Operations) $131,527 $0 $15,617
Winston Wicomb (Director, Vivarium Thru 05/20) $117,795 $0 $4,635
Darren Klemkow (Director, Facilities & Procurement) $115,589 $0 $24,918
Jeffrey Guderian (Director, Laboratory Management) $111,372 $0 $16,402
Shelly Crocker (Receiver) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$21,976,016
Expenses
$29,046,899
Net Income
-$7,070,883
Net Assets
-$3,359,119
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,251,999
51.2%
Program Services $11,179,733
50.9%
Investment Income $3,308
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $10,128
0.0%
Net Fundraising $0
Sales of Assets -$469,139
Net Inventory Sales $0
Other Revenue -$13
Notable Expenses Percent of Total Expenses
Executive Compensation $2,659,118
9.2%
Professional Fundraising Fees $0
Other Salaries and Wages $7,447,515
25.6%
Assets/Debt
Total Assets $16,784,379
Total Liabilities $20,143,498
Net Assets -$3,359,119
Compensation
Key Employees and Officers Compensation Related Other
Michael Bassof (Evp, Philanthropy) $416,199 $0 $23,971
Corey Casper (Interim President & Ceo) $388,432 $0 $23,147
Steven Reed Ph D (Founder, Distinguished Investigator) $359,201 $0 $27,246
Anna Marie Beckmann (Svp, Development & Regulatory) $240,005 $0 $28,767
Tanya Parish (Svp, Drug Discovery) $216,265 $0 $9,392
Rhea Coler (Svp, Pre Clin. & Transl. Research) $214,552 $0 $24,393
Winston Wincomb (Dir. Of Vivarium) $182,577 $0 $21,738
Christopher Antony (Vp, Operations) $156,845 $0 $12,855
Christopher Fox (Vp, Formulations) $156,665 $0 $26,646
Linda Hawkins (Dir. Quality Assurance & Compliance) $151,555 $0 $22,114
Ryan Kramer (Dir., Process & Product Dev.) $137,544 $0 $23,084
Robrick Smith (Dir., Information Technology) $134,879 $0 $24,173
Aude Frevol (Assoc. Director, Clinical Ops.) $131,927 $0 $25,168
Jesse Erasmus (Postdoctoral Fellow) $126,159 $0 $23,493
Erik Laursen (Director, Gmp Operations) $125,628 $0 $14,953
Richard Lautch (Coo) $53,071 $0 $2,780
Franklyn Prendergast Md Phd (Chairman) $0 $0 $0
Norman Baylor Ph D (Director) $0 $0 $0
Michel Dewilde Ph D (Director) $0 $0 $0
Massimo Radaelli Ph D (Director) $0 $0 $0
Jerry Mcdougall (Director) $0 $0 $0
Erik Iverson (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$28,954,130
Expenses
$29,001,021
Net Income
-$46,891
Net Assets
$4,962,168
Notable Sources of Revenue Percent of Total Revenue
Contributions $15,418,545
53.3%
Program Services $13,483,827
46.6%
Investment Income $31,677
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $13,761
0.0%
Net Fundraising $0
Sales of Assets $6,856
0.0%
Net Inventory Sales $0
Other Revenue -$536
Notable Expenses Percent of Total Expenses
Executive Compensation $1,560,642
5.4%
Professional Fundraising Fees $0
Other Salaries and Wages $8,926,714
30.8%
Assets/Debt
Total Assets $28,838,131
Total Liabilities $23,875,963
Net Assets $4,962,168
Compensation
Key Employees and Officers Compensation Related Other
Cory Casper (Chief Scientific Officer) $324,800 $0 $19,198
Steven Reed Phd (President & Ceo/Director) $317,679 $0 $23,713
Anna Marie Beckmann Phd (Svp, Development & Regulatory) $217,439 $0 $25,846
Tanya Parish Phd (Svp, Drug Discovery) $194,843 $0 $7,178
Winston Wicomb (Director, Vivarium) $191,077 $0 $15,660
Richard Lautch (Coo/Director) $175,742 $0 $6,800
Mary Thomson (General Counsel & Secretary) $171,554 $0 $9,959
Lee Schoentrup (Dir., Communications) $145,969 $0 $11,602
Christopher Antony (Vp, Operations Eh&S Officer) $145,963 $0 $10,609
Linda Hawkins (Dir., Quality Assurance/Compliance) $142,312 $0 $14,271
Christopher Fox (Vp, Formulations) $141,155 $0 $20,307
C Stephen Cordial Mba (Cfo/Director Thru 03/18) $62,595 $0 $3,296
Bruce Carter Phd (Chairman Thru 04/18) $0 $0 $0
Franklyn Prendergast Md Phd (Chairman) $0 $0 $0
Norman Baylor Phd (Director) $0 $0 $0
Michel Dewilde Phd (Director) $0 $0 $0
Massimo Radaelli Phd (Director) $0 $0 $0
Erik Iverson Jd Llm (Director) $0 $0 $0
Kari Stoever (Director Thru 04/18) $0 $0 $0
Cindy Runger (Director Thru 04/18) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$23,589,460
Expenses
$27,635,631
Net Income
-$4,046,171
Net Assets
$6,355,255
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,656,120
49.4%
Program Services $11,159,561
47.3%
Investment Income $24,767
0.1%
Bond Proceeds $0
Royalties $916,304
3.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$237,599
Net Inventory Sales $0
Other Revenue $70,307
0.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,745,271
6.3%
Professional Fundraising Fees $0
Other Salaries and Wages $9,027,746
32.7%
Assets/Debt
Total Assets $27,284,376
Total Liabilities $20,929,121
Net Assets $6,355,255
Compensation
Key Employees and Officers Compensation Related Other
Steven Reed Phd (President & Ceo/Director) $350,123 $0 $22,941
Dan Stinchcomb (Chief Scientific Officer) $255,131 $0 $26,180
C Stephen Cordial Mba (Cfo/Director) $210,265 $0 $13,046
Anna Marie Beckmann Phd (Svp, Product Development & Regulatory) $199,400 $0 $24,018
Tanya Parish Phd (Svp, Drug Discovery) $188,624 $0 $6,956
Corey Casper (Chief Medical Officer) $184,381 $0 $13,841
Douglas Bradley (General Counsel/Secretary) $179,290 $0 $11,721
Winston Wicomb (Director, Vivarium) $166,348 $0 $16,291
Christopher Fox (Vp, Formulations) $156,808 $0 $22,968
Lee Schoentrup (Dir., Communications) $143,720 $0 $9,651
Christopher Antony (Vp, Operations Eh&S Officer) $139,504 $0 $10,080
Linda Hawkins (Dir., Quality Assurance & Compliance) $136,474 $0 $10,055
Richard Lautch (Director) $31,875 $0 $0
Gail Cassel Phd (Director) $27,480 $0 $0
Bruce Carter Phd (Chairman) $0 $0 $0
Norman Baylor Phd (Director) $0 $0 $0
Michel Dewilde Phd (Director) $0 $0 $0
Erik Iverson Jd Llm (Director) $0 $0 $0
Chris Hentschel Phd (Director Thru 02/17) $0 $0 $0
Franklyn Prendergast Md Phd (Director) $0 $0 $0
Massimo Radaelli Phd (Director) $0 $0 $0
Kari Stoever (Director) $0 $0 $0
Cindy Runger (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$20,738,545
Expenses
$25,066,156
Net Income
-$4,327,611
Net Assets
$11,464,675
Notable Sources of Revenue Percent of Total Revenue
Contributions $10,066,730
48.5%
Program Services $9,598,506
46.3%
Investment Income $3,059
0.0%
Bond Proceeds $0
Royalties $1,000,571
4.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $61,463
0.3%
Net Inventory Sales $0
Other Revenue $8,216
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,407,105
5.6%
Professional Fundraising Fees $0
Other Salaries and Wages $8,263,346
33.0%
Assets/Debt
Total Assets $32,396,570
Total Liabilities $20,931,895
Net Assets $11,464,675
Compensation
Key Employees and Officers Compensation Related Other
Steven Reed Phd (President & Ceo/Director) $402,622 $0 $19,079
Anna Marie Beckmann Phd (Svp, Product Dev & Regulatory) $194,666 $0 $23,831
Douglas Bradley (General Counsel & Secretary) $194,086 $0 $13,008
Darrick Carter (Vp, Adjuvant Technology) $185,872 $0 $1,272
Tanya Parish Phd (Svp, Drug Discovery) $173,099 $0 $6,968
Winston Wicomb Phd (Director, Vivarium) $165,453 $0 $18,153
Erik Iverson Jd Llm (Pres. Of Bus & Ops/Secretary) $152,998 $0 $14,444
Kim Clary (Vp, Alliance Management) $148,852 $0 $22,602
Joshua Odingo Phd (Director, Chemistry) $144,389 $0 $20,852
Lee Schoentrup (Director, Communications) $138,371 $0 $5,559
Robert Lin (Vp, Finance Thru 07/16) $105,837 $0 $14,243
C Stephen Cordial Mba (Cfo/Treasurer) $92,224 $0 $0
Bruce Carter Phd (Chairman) $0 $0 $0
Norman Baylor Phd (Director) $0 $0 $0
Gail Cassel Phd (Director) $0 $0 $0
Michel Dewilde Phd (Director) $0 $0 $0
Chris Hentschel Phd (Director) $0 $0 $0
Franklyn Prendergast Md Phd (Director) $0 $0 $0
Massimo Radaelli Phd (Director) $0 $0 $0
Kari Stoever (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$28,299,402
Expenses
$25,105,840
Net Income
$3,193,562
Net Assets
$15,885,497
Notable Sources of Revenue Percent of Total Revenue
Contributions $19,664,811
69.5%
Program Services $6,098,639
21.6%
Investment Income $5,521
0.0%
Bond Proceeds $0
Royalties $1,667,416
5.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $851,642
3.0%
Net Inventory Sales $0
Other Revenue $11,373
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $769,201
3.1%
Professional Fundraising Fees $0
Other Salaries and Wages $7,991,191
31.8%
Assets/Debt
Total Assets $37,205,100
Total Liabilities $21,319,603
Net Assets $15,885,497
Compensation
Key Employees and Officers Compensation Related Other
Steven Reed Phd (President & Cso/Director) $302,134 $0 $23,157
Erik Iverson Jd Llm (Pres., Business & Ops, Secretary) $284,942 $0 $25,904
Anna Marie Beckmann Phd (Vp, Development & Regulatory) $185,988 $0 $24,295
Tanya Parish Phd (Vp, Drug Discovery) $161,860 $0 $5,992
Winston Wicomb Phd Latg (Director, Vivarium) $156,409 $0 $17,059
Kim Clary (Director, Ip) $143,715 $0 $22,754
Joshua Odingo Phd (Director, Chemistry) $142,045 $0 $21,234
Robert Lin (Vp, Finance) $126,159 $0 $6,905
Bruce Carter Phd (Chairman) $0 $0 $0
David Perry (Treasurer) $0 $0 $0
Gail Cassell Phd (Director) $0 $0 $0
Michel Dewilde Phd (Director) $0 $0 $0
Chris Hentschel Phd (Director) $0 $0 $0
Franklyn Prendergast Md Phd (Director) $0 $0 $0
Massimo Radaelli Phd (Director) $0 $0 $0
Steve Cordial (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$14,165,328
Expenses
$24,335,307
Net Income
-$10,169,979
Net Assets
$16,314,215
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,413,720
66.5%
Program Services $4,038,190
28.5%
Investment Income $8,063
0.1%
Bond Proceeds $0
Royalties $719,744
5.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$14,389
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $890,425
3.7%
Professional Fundraising Fees $958
0.0%
Other Salaries and Wages $7,935,489
32.6%
Assets/Debt
Total Assets $36,163,621
Total Liabilities $19,849,406
Net Assets $16,314,215
Compensation
Key Employees and Officers Compensation Related Other
Steven Reed Phd (President & Cso/Director) $297,670 $0 $10,949
Erik Iverson Jd Llm (President, Business & Ops/Director) $275,049 $0 $9,949
Anna Marie Beckmann (Vp, Development & Regulatory) $176,465 $0 $9,338
Robert Lin (Vp, Finance) $150,532 $0 $8,960
Tanya Parish (Vp, Drug Discovery) $148,971 $0 $8,752
Winston Wicomb (Director, Vivarium) $146,387 $0 $8,757
Joshua Odingo (Director, Chemistry) $137,466 $0 $8,568
Thomas Vedvick (Vp, Formulation/Process Development) $134,667 $0 $8,481
H Stewart Parker (Former Ceo/Director) $78,188 $0 $7,311
Curt Malloy (Former Svp, Ops & General Counsel) $49,369 $0 $2,448
David Maki Jd (Chairman/Treasurer) $0 $0 $0
David Webster (Secretary) $0 $0 $0
Bruce Carter (Director) $0 $0 $0
Eric Easom (Director) $0 $0 $0
Chris Hentschel Phd (Director) $0 $0 $0
David Perry (Director) $0 $0 $0
Franklyn Prendergast Md (Director) $0 $0 $0
Massimo Radaelli (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$13,850,980
Expenses
$25,923,116
Net Income
-$12,072,136
Net Assets
$25,338,798
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,743,860
84.8%
Program Services $1,460,223
10.5%
Investment Income $25,437
0.2%
Bond Proceeds $0
Royalties $658,559
4.8%
Rental Property Income $325
0.0%
Net Fundraising $0
Sales of Assets -$37,924
Net Inventory Sales $0
Other Revenue $500
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,400,737
5.4%
Professional Fundraising Fees $24,838
0.1%
Other Salaries and Wages $8,017,853
30.9%
Assets/Debt
Total Assets $45,214,688
Total Liabilities $19,875,890
Net Assets $25,338,798
Compensation
Key Employees and Officers Compensation Related Other
H Stewart Parker (Ceo/Director) $387,295 $0 $11,349
Steven Reed Phd (President & Cso/Director) $369,191 $0 $11,349
Erik Iverson Jd Llm (Evp, Business Develop & Ext Affairs) $229,715 $0 $10,449
Curt Malloy (Svp, Operations & General Counsel) $213,723 $0 $10,374
Anna Marie Beckmann (Vp, Development & Regulatory) $159,960 $0 $9,465
Rhea Coler (Vp, Pre Clinical Biology) $157,442 $0 $9,249
Robert Lin (Vp, Finance) $147,907 $0 $9,385
Winston Wicomb (Director, Vivarium) $143,836 $0 $9,199
Joshua Odingo (Director, Chemistry) $134,229 $0 $8,406
Thomas Vedvick (Vp, Formulation/Process Development) $131,838 $0 $8,309
David Maki Jd (Chairman) $0 $0 $0
David Webster (Secretary/Treasurer) $0 $0 $0
Massimo Radaelli (Director) $0 $0 $0
Eric Easom (Director) $0 $0 $0
Chris Hentschel Phd (Director) $0 $0 $0
David Perry (Director) $0 $0 $0
Franklyn Prendergast Md (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$22,956,470
Expenses
$24,385,590
Net Income
-$1,429,120
Net Assets
$37,407,735
Notable Sources of Revenue Percent of Total Revenue
Contributions $20,127,852
87.7%
Program Services $2,779,545
12.1%
Investment Income $38,260
0.2%
Bond Proceeds $0
Royalties $657,929
2.9%
Rental Property Income -$647,116
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $1,268,447
5.2%
Professional Fundraising Fees $0
Other Salaries and Wages $7,767,351
31.9%
Assets/Debt
Total Assets $49,538,156
Total Liabilities $12,130,421
Net Assets $37,407,735

Document Links

Fiscal Year Ending Dec.
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$17,216,425
Expenses
$23,284,958
Net Income
-$6,068,533
Net Assets
$38,833,254
Notable Sources of Revenue Percent of Total Revenue
Contributions $14,410,786
83.7%
Program Services $2,463,111
14.3%
Investment Income $53,600
0.3%
Bond Proceeds $0
Royalties $427,807
2.5%
Rental Property Income -$152,584
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $13,705
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $832,687
3.6%
Professional Fundraising Fees $0
Other Salaries and Wages $6,810,661
29.2%
Assets/Debt
Total Assets $42,428,324
Total Liabilities $3,595,070
Net Assets $38,833,254

Document Links

Fiscal Year Ending Dec.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2006

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2002

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2001

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »